Davis's Drug Guide
Embeda 80/3.2
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Embeda 80/3.2." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110023/all/Embeda_80_3_2.
Vallerand AHA, Sanoski CAC, . Embeda 80/3.2. Davis's Drug Guide. F.A. Davis Company; 2024. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110023/all/Embeda_80_3_2. Accessed January 14, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2024). Embeda 80/3.2. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110023/all/Embeda_80_3_2
Vallerand AHA, Sanoski CAC, . Embeda 80/3.2 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2025 January 14]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110023/all/Embeda_80_3_2.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Embeda 80/3.2
ID - 110023
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110023/all/Embeda_80_3_2
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
